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Risk of bias assessment in credible quasi-experimental studies1 
Hugh Waddington, Ariel Aloe, Betsy Becker, Barney Reeves, Peter Tugwell and George 
A. Wells 
Abstract: Rigorous and transparent critical appraisal is a core component of high quality 
systematic reviews. Well-conducted quasi-experiments have been empirically shown to 
estimate credible, unbiased treatment quantities. Conversely, when inappropriately designed 
or executed, these estimates are likely to be biased. This paper draws on recent advances in 
risk of bias assessment. It presents an approach to evaluating the internal validity of credible 
quasi-experiments. These are non-randomised studies using design-based approaches to 
control for unobservable sources of confounding such as difference studies, instrumental 
variables, interrupted time series, natural experiments and regression discontinuity designs. 
Our review suggests that existing risk of bias tools provide, to different degrees, incomplete 
transparent criteria to assess the validity of credible quasi-experiments. We argue that a tool 
is needed to assess risk of bias consistently across credible quasi-experiments. Drawing on 
existing tools, in particular Cochrane’s new tool for non-randomized studies of interventions 
(Sterne et al., 2014), we discuss domains of bias and suggest directions for evaluation 
questions.  
Keywords: risk of bias, systematic review, meta-analysis, quasi-experiment, natural 
experiment, instrumental variables, regression discontinuity, interrupted time series, 
difference in differences, propensity score matching 
                                                          
1 Thanks are due to David Wilson for suggesting the term ‘credible quasi-experiments’ at the Campbell 
Collaboration Methods Group Symposium in Belfast, May 2014, as well to other participants at that meeting 
and participants the Alliance for Health Systems Research workshop on quasi-experimental studies at Harvard 
School of Public Health, November 2013.  
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1. Introduction 
Researchers in health and the social sciences quantify statistically valid treatment effects – 
that is, changes in outcomes which are attributed to a particular treatment – using a range of 
credible quasi-experimental approaches (Dunning, 2012; Reeves et al., this issue). Quasi-
experiments are referred to by various names including natural experiments,2 observational 
studies or simply non-randomized studies.3 ‘Credible quasi-experiments’ are defined here as 
approaches that use rigorous designs and methods of analysis which can enable studies to 
adjust for unobservable sources of confounding. Approaches discussed explicitly in this paper 
are difference-in-differences, instrumental variables, interrupted time-series, natural 
experiments, and regression discontinuity designs. Often these designs are combined with 
methods to control for observable confounding such as statistical matching (e.g. propensity 
score matching, PSM) and adjusted regression analysis.  
All quantitative causal studies are subject to biases relating to design (internal validity) and 
methods of analysis (statistical conclusion validity) (Shadish et al., 2002). In the same way 
that experimental studies (randomized controlled trials, RCTs) can have methodological 
problems in implementation (for example, contagion (contamination), poor allocation 
concealment, non-random attrition, and so on), inappropriately designed or executed quasi-
experiments will not generate good causal evidence. Quasi-experimental studies are, 
however, potentially at higher risk of bias than their experimental counterparts (Higgins et al., 
2012; Rubin, 1974), with perhaps the most critical biases for causal inference being 
confounding and bias in selection of the reported result. They are also harder to assess than 
                                                          
2A UK Medical Research Council (Craig et al. 2011) guidelines refers to on quasi-experimental designs as 
‘natural experiments’; we use ‘natural experiment’ to refer specifically to designs where exogenous variation in 
treatment exists, for example due to random errors in treatment targeting and geographical variation. 
3 Randomized studies are defined here as studies in which assignment to the intervention of interest is 
determined randomly.  
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RCTs, requiring greater qualitative appraisal of potential biases, which in many cases may 
need to draw on advanced theoretical and statistical knowledge.  
Systematic critical appraisal, operationalized through ‘risk of bias’ assessment, provides 
assurance of the credibility of causal studies (Higgins and Green, 2011) and their 
trustworthiness for decision-making (Chalmers, 2014). Risk of bias tools provide 
transparency about the judgments made by reviewers when performing assessments. They are 
usually organized around particular domains of bias, and provide the specific ‘signaling 
questions’ which enable reviewers to evaluate the likelihood of bias.  
This paper discusses how to operationalize risk of bias assessment for credible quasi-
experiments. Section 2 discusses internal validity and Section 3 reviews existing risk of bias 
tools. Section 4 presents proposed evaluation criteria and signaling questions. Section 5 
concludes by proposing an agenda for research in the further development of a risk of bias 
tool.  
2. Internal validity of credible quasi-experiments 
Habicht and Victora (1999) distinguish probability evaluation designs, which are able to 
quantify with statistical precision the change in outcomes attributed to a treatment, from 
plausibility designs, which attempt to rule out observable confounding but are unable to 
address important sources of bias, in particular those arising from unobservables.4 These 
authors explicitly limit probability evaluations to randomized controlled trials. However, 
evidence is emerging which suggests quasi-experiments which are able to address 
                                                          
4 A third category, adequacy evaluations refers to descriptive methods which are not able to address 
confounding (e.g., uncontrolled pre-test post-test studies where no attempt is made to rule out external factors 
which may explain observed changes in outcomes) (Habicht and Victora, 1999). These would include single 
case quasi-experimental designs and other ‘small n’ approaches.   
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unobservable confounding can produce the same effect sizes as RCTs in pooled analysis 
(Table 1).5,6  
Table 1 Pooled effects of RCTs and credible quasi-experiments 
Treatment Design Pooled 
odds ratio4 
95% confidence 
interval 
P>|z| Tau-sq I-Sq Num obs 
Conditional 
cash transfer 
(vs control)1 
RCT 1.43 1.21 1.69 0.000 0.05 90.8% 15 
RCT and 
QE 
1.43 1.28 1.59 0.000 0.04 88.7% 22 
Education 
intervention 
(vs standard 
intervention)2 
RCT 1.33 1.20 1.46 0.000 0.02 90.9% 43 
QE 1.34 1.20 1.52 0.000 0.02 96.7% 16 
Microcredit 
(vs control)3 
RCT 0.99 0.93 1.05 0.437 0.00 0.0% 4 
QE 0.99 0.88 1.12 0.074 0.00 61.6% 3 
Notes: 1/ Baird et al. (2013); outcome is school enrolment. 2/ Petrosino et al. (2012); outcomes is school 
enrolment and attendance. 3/ Vaessen et al. (2014); outcome is ‘woman makes household spending decisions’. 
4/ Pooled odds ratios estimated by inverse-variance weighted random effects meta-analysis. Quasi-experiments 
(QE) included in the analyses are difference-in-differences, instrumental variables, propensity score matching 
and regression discontinuity. Source: author calculations based on reported data. 
Credible quasi-experiments account for unobservable confounding by design, either through 
knowledge about the method of allocation or in the methods of analysis used. They are 
                                                          
5 We note that authors and journal editors may have incentives for selective publishing of favorable comparisons 
between randomized and non-randomized studies. The examples presented in Table 1 are from systematic 
reviews (SRs) of socio-economic interventions in low- and middle-income countries supported by the Campbell 
Collaboration International Development Coordinating Group (IDCG). The findings on experimental and quasi-
experimental approaches are representative of the body of evidence in SRs supported by the IDCG. Other 
examples of comparisons of RCTs and quasi-experiments include Lipsey and Wilson (1993) who provide a 
meta-analysis of North American social programs and Vist et al. (2009) who compare RCTs and cohort studies 
in health care studies. Evidence is also available from (within-study) design replication – that is, studies which 
attempt to compare the same experimental treatment groups with non-randomized comparison groups using 
quasi-experimental methods. One meta-study suggested significant differences between results from RCTs and 
quasi-experiments for US and European labor market programs (Glazerman et al., 2003). However, design 
replications using well-conducted quasi-experimental methods, in which participation has been carefully 
modelled, have also shown the same results as the RCTs they are replicating (Cook et al., 2008; Hansen et al., 
2011).  
6 As noted by Duvendack et al. (2012), effect sizes estimated from credible quasi-experiments may differ 
empirically from those from RCTs due to differences in external validity – that is, due to the population sampled 
and the type of treatment effect estimated (see also Aloe et al., this issue).  
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considered more credible than approaches which rely solely on covariate adjustment of 
observable confounders (Dunning, 2012; Shadish et al. 2002), whose validity usually relies 
on unverifiable assumptions about the strength of the correlation between confounding that 
can be observed and that which cannot (i.e., that observables and unobservables are strongly 
correlated).  
In quasi-experimental designs that use information about the method of allocation to estimate 
a treatment effect, the ability of the study to identify a causal relationship rests on 
assumptions that the identifying variables which determine assignment are highly correlated 
with treatment status but not caused by the outcomes of interest (reverse causality) nor related 
to any of the other causes of the change in outcome (observable and unobservable 
confounding) – that is, they are ‘exogenous’. This is the same rationale on which randomized 
assignment is based, hence we adopt the term ‘as-if randomized’ (Dunning, 2010) for quasi-
experimental designs which are, in theory, able to account for all sources of confounding, 
including unobservables. We differentiate these designs from ‘non-randomized’ quasi-
experiments which are only able to account for observable confounding and unobservables 
under particular conditions (Figure 1).  
‘As-if randomized’ quasi-experiments include instrumental variables (IV), interrupted time 
series (ITS), natural experiments (NE) and regression discontinuity (RD) designs. In natural 
experiments treatment is assigned ‘as-if randomly’ due to decisions in implementation or 
take-up, for example by an arbitrary boundary, whether by service provision jurisdiction 
(Snow and Richardson, 1965) or perhaps according to treatment practice (e.g., Zafar et al., 
2014), errors in implementation (e.g., Morris et al., 2004), or manipulated by researchers who 
are using ‘randomized encouragement’, where participants are exposed randomly to 
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information about an intervention which itself may be universally available (King et al., 
2009).7 We may also include non-random methods of assignment such as alternation here.  
‘As-if randomized’ quasi-experiments also include regression-discontinuity designs (RD) 
which exploit local variation around a cut-off on an ordinal or continuous ‘forcing’ variable 
used by decision-makers to determine treatment.8 Examples include treatment assignment by 
diagnostic test score (e.g., Bor et al., 2014), age (e.g., Card et al., 2009), or date as in multiple 
case-series interrupted time-series (ITS) design.9 
In the special case of instrumental variables (Zohoori and Savitz, 1997) and related 
approaches,10 researchers use such exogenous variables to model treatment decisions in 
multiple-stage regression (e.g., 2-stage least squares or simultaneous equations maximum 
likelihood). Exogenous variables used in IV estimation include all of the variables mentioned 
above, such as randomized assignment or encouragement, differences in implementation 
across groups (e.g., Wang et al., 2007) and, frequently, geographical factors such as 
distance11 (e.g., Newhouse and McClellan, 1998), weather or climate conditions (Lawlor et 
al., 2006) and topography (e.g., Duflo and Pande, 2008), among many others.12  
                                                          
7 ‘Randomized encouragement’ designs are classified as natural experiments because the relationship of interest 
in the study is not usually the pragmatic question about the effect of such encouragement, but rather the 
mechanistic question about the effect of the intervention in people who are responsive to encouragement. A 
randomized encouragement study can be analysed conventionally (using intention-to-treat) or using instrumental 
variables estimation. 
8 Where the forcing variable is not correlated with assignment precisely (e.g. due to performance biases), the 
design is referred to as a ‘fuzzy’ RDD and estimation is done using instrumental variables.  
9 ITS here refers to longitudinal panel datasets measured at the disaggregate level (i.e., the same people 
measured multiple times before and after treatment). It is more common for longitudinal datasets to be clustered 
at aggregate levels of care (e.g., the health facility or district). In such cases, confounding by secular trends 
needs to be assessed, for example with reference to a contemporaneous comparison group (controlled 
interrupted time-series) and an assessment of performance bias.  
10 For example, ‘switching regression’ models (for a practical example, see Lockshin and Sajaia, 2004). 
Instrumental variables methods are also used to analyse experimental data, for example to account for non-
compliance (Imbens and Angrist, 1994; for an illustration of the approach in epidemiology, see Greenland, 
2000). 
11 It is worth noting that location is often endogenous – at least in the long-term, people are able to move to gain 
access to better services. Hence distance of participant to treatment facility may often not be a good instrument.  
12 See Dunning (2012) for a comprehensive overview of instrumental variables approaches.  
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Where allocation rules are not exogenous, confounding must be controlled directly in 
adjusted statistical analyses. Methods such as difference-in-differences (DID, also called 
double differences, DD), triple differences (DDD) and fixed effects (FE) regression applied 
to individual level longitudinal data, enable adjustment for time-invariant unobservable 
confounding (at the level of the unit of analysis) by design, and observable confounding in 
adjusted analyses.13 However, these methods are not able to control for time-varying 
unobservables even in theory. In contrast, single difference (SD) estimation applied to case-
control, cohort or cross-sectional data (or in PSM when matching is on baseline 
characteristics14) is not able in theory to control for time-varying or time-invariant 
unobservables, except in the special case of selection on observables.  
In Figure 1, we group these study designs and methods of analysis into three groups ordered 
from top to bottom according to a priori internal validity in addressing confounding. 
Randomized experiments and ‘as-if randomized’ design-based quasi-experiments are 
considered the most credible methods in theory. Non-randomized quasi-experiments are 
considered less credible in theory, with differencing methods applied to individual level data 
being favored over non-randomized studies relying solely on analysis of observables.  
The choice of design for a comparative assessment should capture the information needed to 
classify a study in this proposed hierarchy (see also Reeves et al., this issue). However, the 
extent to which designs produce valid causal inferences in practice also depends on the 
quality of implementation of the approach and the statistical conclusions drawn (see also 
Vandenbroucke, 1989). Particular flaws in implementation can lead to studies being assessed 
as being of lower quality than suggested by the a priori categories in Figure 1; indeed we 
                                                          
13 Difference studies can only adjust for unobservable confounding at the unit of analysis, hence it is important 
to distinguish studies where data analysis is at the individual level, from those where data analysis is conducted 
at the aggregate level such as the practitioner, health facility, and community or higher.  
14 Difference studies should usually be accompanied by statistical matching (e.g., propensity score matching, 
PSM) in order to identify the treatment effect among observations in the region of common support (Heckman, 
1998). 
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would expect many quasi-experiments to be downgraded because the assumptions underlying 
the design are not met.15  
Figure 1 Study design decision flow for causal studies using statistical methods
Source: Authors draw on Waddington et al. 2012. 
                                                          
15 Conversely, strong implementation might in rare cases lead to studies being assessed as of higher quality. An 
example would be a SD study where selection of participants is based on observable characteristics which are 
measured at baseline and appropriately modelled in the analysis.  
Randomized assignment by researchers 
or decision-makers? 
RCT 
‘As-if randomized’ assignment by 
researchers or decision-makers (e.g. 
alternation or political jurisdiction)? 
NE 
‘As-if randomized’ assignment by 
forcing variable (e.g. test score or, in 
the case of ITS, date)? 
RD 
‘As-if randomized’ assignment 
determined by researchers in multi-
stage estimation? 
IV 
Non-randomized assignment with 
control for unobservable time-invariant 
confounding (e.g. innate ability) 
DID 
Non-randomized assignment with 
control for observable confounding 
only  
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randomized’ 
quasi-experiment 
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quasi-experiment 
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Yes 
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No 
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Risk of bias assessment should therefore incorporate design assessment and implementation 
of analysis (Littell et al., 2008). While the underlying domains of bias (e.g., confounding, 
biases in outcomes data collection and reporting etc.) are relevant across designs, the criteria 
used to verify them may differ between ‘as-if randomized’ and non-randomized study groups 
and even within groups themselves. For instance, let Z be an exogenous variable determining 
assignment, T be a dummy variable representing treatment assignment, and Y be the outcome 
of interest. For ‘as-if randomized’ studies (NE, IV and RD), the validity assessment will need 
to incorporate the following criteria: information provided about the relationship between Z 
and T – in particular, nonzero and monotonic causal relationship between Z and T (Bound et 
al., 1995); the relationship between Z and Y – that is, Z is not affected by Y or any of its 
causes and only affects Y through T (exogeneity, also called the ‘exclusion restriction’); and 
the relationship between treated units – Z for one treatment unit does not affect T for another 
treatment unit (crossovers), T for one treatment unit does not affect Y for another treatment 
unit (spillovers) and there is no variation in T across treatment units (e.g. due to measurement 
errors) – collectively referred to as the ‘stable unit treatment value assumption’ (Chiba, 
2010).16 However, the ‘signaling questions’ on which each of these propositions can be 
verified will differ between NE, IV and RD. For example, IV and RD require greater 
assessment of the statistical methods (e.g., the appropriate bandwidth around forcing variable 
and functional form specification for RD). The assessment of non-randomized quasi-
experiments will be based on different criteria and different signaling questions (Figure 2). 
                                                          
16 The degree of homogeneity of the relationship between T and Y across individuals induced to treatment by Z 
is also of interest for external validity (Angrist & Pischke, 2009). See also fn. 6. 
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Figure 2 Assumptions underpinning validity of credible quasi-experiments 
Natural experiments and instrumental variables: 
• Relationship between assignment variable and treatment status is monotonic and highly correlated 
• Assignment variable does not affect the outcome except through treatment (the ‘exclusion 
restriction’) 
• Assignment variable is not caused by nor shares causes with the outcome 
• Stable unit treatment value assumption (SUTVA) is satisfied 
• There is sufficient variation in assignment variable and appropriate regression specification used for 
instrumental variables 
 
Regression discontinuity and interrupted time series: 
• Forcing variable is continuous, or at least ordinal with sufficient values 
• Forcing variable is not confounded by other causes of the outcome (e.g. it is not used to determine 
allocation to another relevant intervention which affects outcome) 
• Forcing variable is not anticipated or manipulable by participants  
• Forcing variable determines assignment (SUTVA is satisfied) 
• Appropriate bandwidth around forcing threshold and regression specification 
 
Difference studies: 
 
• Differencing (or use of fixed effects) controls for all unobservable time-invariant confounding at 
the level of the unit of analysis 
• All observable sources of time-varying confounding are controlled in adjusted analysis and these 
are correlated with time-varying unobservable confounding 
• Differencing controls for unobservable time varying confounding (the equal trends assumption) 
• Comparable observations are used across groups (common support) 
 
Sources: Gertler et al. (2012), Hombrados & Waddington (2012), Schochet et al. (2010). 
 
3. Review of critical appraisal tools 
A large number of tools exist to facilitate risk of bias assessment of non-randomized causal 
studies. Drawing on the systematic review by Deeks et al. (2003) and a search of more recent 
literature, we selected and appraised relevant risk of bias tools according to the extent to 
which they identified evaluation criteria and signalling questions for credible quasi-
experiments as defined here (Table 2). We included tools aiming to assess both randomized 
and non-randomized studies (Downs & Black, 1998; Cochrane Effective Practice and 
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Organisation of Care (EPOC), undated17; Hombrados & Waddington, 2012; National Institute 
for Health and Clinical Excellence (NICE), 2009; Reisch, 1989; Sherman et al., 1998; 
Scottish Intercollegiate Guidelines Network (SIGN), 2011; Valentine & Cooper, 2008; West 
et al., 2002). We also included tools aiming to appraise only non-randomized studies 
(Cowley, 1995; Effective Public Health Practice Project (EPHPP), undated; Kim et al., 2013; 
Sterne et al., 2014; Wells, undated).  
Our analysis indicated that existing tools contain evaluation criteria for domains of bias that 
are relevant to credible quasi-experiments as defined here. However, most of the tools were 
not designed to assess causal validity of these studies, meaning that the ‘signalling questions’ 
on which biases are evaluated were not sufficiently relevant, particularly in the domains of 
confounding and reporting biases. For example, randomization (sequence generation and 
allocation concealment) is usually the only method to account for unobservable confounding 
that is assessed. No single tool fully evaluated the internal or statistical conclusion validity of 
credible quasi-experimental designs defined here, including the recent tool by Sterne et al. 
(2014) which was operationalized for designs more commonly used in health research such 
as cohort and case-control designs. Only one tool addressed instrumental variables design and 
statistical matching methods (Hombrados & Waddington, 2012) and three tools presented 
signalling questions for discontinuity designs, of which the most comprehensive was 
Schochet et al. (2010). Furthermore, most tools which addressed controlled before and after 
data (e.g., EPOC, n.d.) did not assess the degree to which time-varying unobservables at the 
unit of analysis (e.g., patient, practitioner or health facility) were controlled using DID 
methods applied to disaggregate level data. Most tools that aimed to assess experimental and 
quasi-experimental studies did not enable consistent classification of experimental and quasi-
experimental studies, or of different quasi-experimental designs, across similar evaluation 
                                                          
17 The EPOC tool was developed drawing on the Cochrane risk of bias tool (Higgins et al., 2011).  
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criteria (e.g., NICE, 2009). One tool (Hombrados & Waddington, 2012) attempted to enable 
consistent assessment by evaluation criteria, but it was not sufficiently operationalized to 
capture a priori validity according to the design used in the study (see Figure 1). 
Table 2 Assessment of experiments and quasi-experiments in existing critical appraisal tools 
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Cowley (1995) NA N N N P N 
Cochrane EPOC (undated) Y N N N P P* 
Downs and Black (1998) Y N N N N N 
EPHPP (undated) Y N N N P N 
Hombrados and Waddington (2012) Y P Y P N Y 
Kim et al. (2013) NA N N N P N 
NICE (2009) Y N N N Y N 
Reisch (1989) Y N N N N N 
Schochet et al. (2010) NA NA NA Y P NA 
Sterne et al. (2014) NA N N N P P 
Valentine and Cooper (2008) Y N N P P P 
SIGN (2011) Y N N N N N 
Wells (undated) NA N N N P N 
West et al. (2002) Y N N N N N 
Notes: Y addresses study design and methods of analysis; P partially addresses these; N does not 
address; NA not applicable. * Includes controlled before and after only.  
 
To take a recent example, the Cochrane Collaboration has recently developed a tool to assess 
risk of bias in non-randomized studies of interventions (Sterne et al., 2014). That tool uses 
sensible evaluation criteria to assess risk of bias, with items grouped at pre-intervention stage 
(baseline confounding and sample selection bias), during intervention (bias in measurement 
of interventions, e.g. due to problems of implementation fidelity or in recalling treatment 
status), and after the intervention has started (time-varying confounding, bias due to 
departures from intended interventions (performance bias), bias due to missing data (e.g. 
attrition), bias in measurement of outcomes, and bias in selection of the reported result). But 
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it does not distinguish separately the ability of a study to control for observable versus 
unobservable sources of confounding, so signalling questions to assess the degree of 
confounding focus solely on methods of observable covariate adjustment. Furthermore, 
important sources of biases for particular quasi-experiments arising from justification of the 
design (e.g., exogeneity of an instrumental variable) and the methods of statistical analysis 
(e.g., bandwidth around a cut-off) are not sufficiently operationalized for credible quasi-
experiments, and some included sources of bias may not be relevant (e.g. non-random 
attrition in a cross-sectional IV study). The concept of the unbiased ‘target trial’ to which all 
non-randomized studies should be compared has been useful in getting reviewers from 
outside of the clinical trials community to think about sources of bias which they may 
previously have been unaware. However, the point about the target trial being unbiased is 
quite crucial, as there are instances where trials may be biased in ways which are not 
applicable to observational studies (e.g. performance bias due to Hawthorne effects, as 
discussed below).  
To summarize, we are not aware of any single tool that sufficiently distinguishes control for 
(unobservable) confounding by design from control for (observable) confounding in analysis, 
for non-randomized studies. Each tool addresses some of the potential biases for particular 
designs, but none provides the specific signalling questions needed to determine whether 
quasi-experiments are credible enough to recommend using the results in practice or policy. 
Application of these instruments is therefore likely to lead to inappropriate risk of bias 
assessment for credible quasi-experiments. 
4. Evaluation criteria for credible quasi-experiments 
In this section we discuss evaluation criteria and potential signalling questions for credible 
quasi-experimental studies. Sterne et al. (2014) categorize seven domains of bias which are 
14 
 
relevant for non-randomized studies: confounding; sample selection bias; bias due to missing 
data; bias in measurement of interventions; bias due to departure from intended interventions; 
bias in measurement of outcomes; and bias in selection of the reported result. These domains 
form the basis of evaluation criteria that can be used to operationalize risk of bias assessment 
for credible quasi-experiments. Our discussion focusses on how these domains apply to 
credible quasi-experiments, recognizing that the categories are also applicable for RCTs.  
Confounding refers to the extent to which causality can be attributed to factors determining 
outcomes other than the intervention. Confounding factors that have been shown to influence 
outcomes include self-selection and program placement biases (Sterne et al., 2014). Sources 
of confounding may be observable or unobservable, and time-invariant (identified at 
baseline) or time-varying. Studies using quasi-experimental approaches need to argue 
convincingly, and present appropriate results of statistical verification tests, that the 
identifying variable determining treatment assignment is exogenous to outcomes, and/or that 
the methods of analysis are able to control for unobservable (time-varying and time-invariant) 
confounding (see Hombrados & Waddington, 2012). For example, data permitting, it is 
useful to make assessments of group equivalence at baseline according to observable 
covariates (Hansen, 2008), under the assumption that these are correlated with unobservables. 
Factors which may invalidate group equivalence during the process of implementation, such 
as time-varying confounding, should also be taken into account in estimation.  
Sample selection bias occurs where some eligible treatment units or follow-up periods are 
excluded from data collection or analysis, and this exclusion is correlated with outcome or 
intervention status. Examples are non-random attrition and censoring of data (e.g., where 
outcomes data are not available due to mortality).18 This is particularly important in 
retrospective studies and studies where baseline data are not available. Assessment is needed 
                                                          
18  Sterne et al. (2014) refer to this as inception/lead-time and immortal time biases.  
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of the extent to which the design and methodology account for sample selection biases (e.g., 
through the use of Heckman error correction). A related domain is bias due to missing data, 
which is a specific source of selection bias due to attrition and incomplete data collection 
(e.g., on outcomes, treatment status or covariates measured at baseline and after) (Sterne et 
al., 2014). Biases due to differential attrition are potentially relevant only in prospective 
studies but biases due to incomplete data collection are relevant for all designs. 
Bias in measurement of interventions is not usually considered problematic where 
information is collected at the time of the intervention from sources not affected by the 
outcomes (e.g., enumerators). It is particularly problematic where information about 
treatment status is from participants after implementation who may have an incentive to 
misreport, or where recalling the intervention (e.g., its dose, frequency, intensity or timing) is 
difficult (Sterne et al., 2014). This source of bias is most likely to occur in retrospective 
studies. 
Bias due to departures from intended interventions encompass cross-overs, spillovers and 
implementation fidelity. Cross-overs or switches (including ‘contamination’ of comparison 
groups) occur where individuals receive a treatment different from that assigned. They are 
problematic in non-blinded prospective trials (and double-blinded RCTs with an adaptive 
design where patients cross over if they do not improve sufficiently), as well as designs 
where the identification strategy relies on a natural experiment, instrumental variable or 
regression discontinuity (due to SUTVA). Assessment should therefore be made of the extent 
to which these are accounted for in design or analysis (such as through intention-to-treat or 
instrumental variables estimation). Spillovers occur when members of the comparison group 
are exposed to treatment indirectly, through contact with treated individuals, and are 
potentially problematic for all controlled studies. Cluster-level analysis may be required to 
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ameliorate these sources of bias and/or an assessment of the geographical or social separation 
of groups may be needed.  
Bias in measurement of outcomes due to recall and courtesy biases is potentially problematic 
in all studies where outcomes data are self-reported. But other forms of motivational bias are 
only likely to arise in prospective trials. The classic case is the presence of Hawthorne and 
John Henry effects affecting motivation of participants when they are aware they are part of a 
trial (particularly when they are subjected to repeated measurement). As another example, 
‘survey effects’ may operate whereby groups are sensitized to information that affects 
outcomes through survey questions and then subjected to repeated measurement (Zwane et 
al., 2011). Such effects are less likely to affect motivation where data are collected outside of 
a trial situation with a clear link to an ‘intervention’, and unlikely to be relevant when data 
are collected at one period of time as in a retrospective cross-sectional only (Hombrados & 
Waddington, 2012). Blinding is frequently advocated to reduce bias in outcomes 
measurement. While it may be impossible to prevent participant knowledge of intervention 
status (especially in evaluations of socio-economic interventions), blinding of outcome 
assessors and data analysts usually is feasible, though seldom used. 
Bias in selection of the reported result corresponds to selective reporting of outcomes (e.g., 
among multiple possible outcomes collected), selective reporting of sub-groups of 
participants, or selective reporting of methods of analysis (e.g., where multiple estimation 
strategies or specifications are used) (Rothstein et al., 2005; Sterne et al., 2014). These types 
of bias are particularly likely to be prevalent in retrospective evaluations based on 
observational datasets (e.g., with many IV analyses), but may also arise in prospective studies 
including RCTs where the method of analysis or outcomes are chosen based on results (e.g., 
DID). Presence of a study protocol (pre-analysis plan) can help determine the likelihood of 
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bias (although it is recognized that many such studies still do not contain such plans), as can a 
strong theoretical approach and the assessment of unusual or uncommon methods of analysis. 
5. Operationalizing the approach 
Higgins et al. (2011) present principles for risk of bias tools for RCTs.19 We argue that 
further development of a tool or tools to assess credible quasi-experiments should firstly, aim 
to build on the bias domains and signaling questions in existing tools used by reviewers, in 
particular those articulated by Sterne et al. (2014).20 Second, the tool should address both the 
conceptual and statistical assumptions underpinning validity. This means that appraisals of, 
for example, the plausibility of ‘as-if randomization’ and the exogeneity of identifying 
variables in the confounding domain will need to be incorporated. The evaluation of quasi-
experiments is notoriously more difficult than that of RCTs, relying to a greater extent on 
what we might call ‘qualitative judgment’ informed by both advanced statistical and 
substantive theoretical knowledge. Appraisal by multiple reviewers and inter-rater reliability 
assessment is therefore crucial (Higgins & Green, 2011).  
Third, an integrated assessment tool, covering multiple study designs (RCTs and multiple 
quasi-experimental approaches), should incorporate a priori validity of the designs as well as 
their execution. Analysis should therefore be based on what is being reported regarding the 
assumptions of the designs and the methods with which they are addressed (Littell et al., 
2008).  
                                                          
19 We believe five of these principles are applicable to risk of bias of quasi-experiments: focusing on internal 
validity, choosing bias domains on theoretical and empirical considerations, reporting bias by outcomes, not 
using quality scales, and requiring judgment in assessments. While it is possible to contact authors to obtain 
information, focusing on bias in the data as opposed to in the information reported is likely to require replication 
which is often infeasible for non-trial evidence. Factors relating to motivation of participants (due to 
observation) are of major concern in trials. For social interventions, expectations (such as placebo effects) may 
form an important mechanistic component in the process of behavior change.  
20 Several of the authors have received funding from the UK Medical Research Council to extend the Cochrane 
non-randomized studies risk of bias tool (Sterne et al., 2014) to incorporate design-based quasi-experimental 
approaches.  
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Finally, it is likely that some of the signaling questions used to operationalize evaluation of 
bias will be design-specific, in particular for confounding and reporting biases. For natural 
experiments and instrumental variables, this will require qualitative appraisal of the 
exogeneity of the identifying variable or instrument. For instrumental variables the 
assessment should also incorporate the significance or goodness-of-fit of the first-stage 
instrumenting equation, the individual significance of the instruments and results of an over-
identifying test (Hombrados and Waddington, 2012). For regression discontinuity, the 
assessment should incorporate whether the forcing variable is continuous, or at least ordinal 
with sufficient values,21 the degree to which assignment is exogenous (i.e., not manipulable 
by participants in response to incentives), comparison of covariate means either side of the 
cut-off point, and an assessment of appropriate specification (band-width and use of 
weighting for matches further from the cut-off point) and functional form (e.g. linear or non-
linear relationship between forcing variable and outcome). For difference studies, 
assessments are needed of the unit of analysis at which the differencing or fixed effects 
occurs (determining whether time-invariant unobervables are ‘differenced away’ at, e.g., 
patient, practitioner or health facility level), covariate balance at baseline, adjustment for 
relevant time-varying covariates, differential attrition, and the existence of equal trends in 
outcomes before intervention across treatment and comparison groups (an indicator of 
whether unobservable confounders are changing differentially across group).  
As in the case of randomized studies, information needed to inform risk of bias judgments in 
quasi-experiments must be collected from the studies (see Higgins & Green, 2011, p. 194-
197; Sterne et al., 2014). When specific information about these assumptions is unknown, 
                                                          
21 Schochet et al. (2010) state that ordinal variables should have at least four unique values below the cut-off and 
four unique values above it.  
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reviewers may attempt to obtain such information from the primary study authors.22 The 
information obtained from risk of bias instruments can be used in a variety of ways 
(Ioannidis, 2011). Some feasible alternatives are to use this information as part of the 
inclusion criteria or to use bias information to create moderator variables for a meta-
regression. Ahn and Becker (2011) and Herbison et al. (2006) present evidence that meta-
analysis should not be weighted by quality scores. As a final point, determining overall risk 
of bias is complicated because the degree of bias is a latent construct (i.e., a construct that is 
not directly observable or measureable), but can be useful (see, e.g., Guyatt et al., 2011). 
While evidence suggests it is not appropriate to determine overall bias using weighted quality 
scales (Juni et al., 1999), reviewers have shown that it is possible to assess overall bias based 
on transparent decision criteria (e.g. the reviews reported in Table 1). Others prefer to code 
separate indicators of particular biases to serve as potential moderator variables.  
6. Conclusions 
Current tools used by reviewers do not provide the means to evaluate consistently and 
appropriately the credibility of quasi-experimental studies to address causality. The paper 
justifies the further development of a comprehensive tool (Sterne et al., 2014), and suggests 
how it might incorporate quasi-experiments. Authors have received funding from the UK 
Medical Research Council to undertake this work. The development of a comprehensive tool 
should be based on several principles. Risk of bias should incorporate a priori internal 
validity information based on the classification of study design and an assessment of the 
implementation of the approach. The tool could usefully be operationalized to recognize 
explicitly credible designs like difference studies, instrumental variables, interrupted time 
                                                          
22 Some reviewers may believe that absence of such information is enough to exclude a study from a review. 
This should be explicitly stated as part of the inclusion criteria. Where studies are eligible for inclusion by stated 
design alone, the presence or absence of this information should be incorporated into risk of bias assessment and 
methods such as meta-regression can be used to explore systematic differences between primary studies that do 
or do not provide this information. 
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series, natural experiments and regression discontinuity, and assess them using consistent 
evaluation criteria across bias domains. It is likely that different signaling questions will be 
required for different designs, particularly to address confounding and the reporting of 
appropriate statistical analyses.  
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